Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Walter Jeske, Mary Lewis, Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, Jawed Fareed, PhD, Sid Mehrota

Blood (2017) 130 (Supplement 1): 4905.

https://doi.org/10.1182/blood.V130.Suppl_1.4905.4905

Published: 2017

Journal Articles

Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications

Zafar Siddiqui, Parul Aggarwal, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Mary Lewis, Schuharazad Abro, MD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD

Blood (2016) 128 (22): 4974.

https://doi.org/10.1182/blood.V128.22.4974.4974

Published: 2016

Journal Articles

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, MD, Walter Jeske, PhD, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD, Mary Lewis

Blood (2016) 128 (22): 2608.

https://doi.org/10.1182/blood.V128.22.2608.2608

Published: 2016

Journal Articles

Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications

Zafar Siddiqui, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Mary Lewis, Rohan Rege, Schuharazad Abro, MD, Jawed Fareed, PhD

Blood (2016) 128 (22): 2622.

https://doi.org/10.1182/blood.V128.22.2622.2622

Published: 2016

Journal Articles

Unlike Heparins Newer Oral Anticoagulants Do Not Interact with HIT Antibodies and Maybe Useful in the Longterm Anticoagulant Management of Heparin Compromised Patients

Bruce E Lewis, MD, Christopher Aranda, Mary Lewis, Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, PhD, Jawed Fareed, PhD

Blood (2011) 118 (21): 2317.

https://doi.org/10.1182/blood.V118.21.2317.2317

Published: 2011

Journal Articles

Comparative Studies on the HIT Antibody Mediated Platelet Aggregation / Serotonin Release by Synthetic Pentasaccharide and Two Chemoenzymatically Synthesized Heptasaccharides

Jeanine M. Walenga, PhD, Chris Aranda, Robert Linhardt, Jian Liu, Mary Lewis, Debra Hoppensteadt, Ph.D., Jawed Fareed, PhD

Blood (2011) 118 (21): 2231.

https://doi.org/10.1182/blood.V118.21.2231.2231

Published: 2011

NARROW

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications

Unlike Heparins Newer Oral Anticoagulants Do Not Interact with HIT Antibodies and Maybe Useful in the Longterm Anticoagulant Management of Heparin Compromised Patients

Comparative Studies on the HIT Antibody Mediated Platelet Aggregation / Serotonin Release by Synthetic Pentasaccharide and Two Chemoenzymatically Synthesized Heptasaccharides

Email alerts

ASH Publications

American Society of Hematology

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications

Unlike Heparins Newer Oral Anticoagulants Do Not Interact with HIT Antibodies and Maybe Useful in the Longterm Anticoagulant Management of Heparin Compromised Patients

Comparative Studies on the HIT Antibody Mediated Platelet Aggregation / Serotonin Release by Synthetic Pentasaccharide and Two Chemoenzymatically Synthesized Heptasaccharides

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only